Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656923 · ClinicalTrials.gov registry record
Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical Trial of Poly-L-Lactic Acid for Adipogenesis and Volumization of the Hip Dell" Study
A clinical trial of Lateral Gluteal Depression, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Active
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT06656923: Active study of Lateral Gluteal Depression, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
NCT06656923 is a study of Lateral Gluteal Depression that is active but no longer recruiting, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06656923, a study of Lateral Gluteal Depression, is active but no longer recruiting, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- ACTIVE NOT RECRUITING
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: use immunofluorescence (IF) on previously obtained biopsies to analyze and quantify changes in adipose tissue of subjects injected with poly-L-lactic acid (PLLA) or saline.
Primary Outcome
Analyzing between PLLA and saline-treated specimens for the following populations: * adipocyte derived stem cells * proliferating adipocyte-derived stem cells * preadipocytes/adipocyte precursors * proliferating preadipocytes/adipocyte precursors * mature adipocytes and actively differentiating precursors The following proteins will be quantified and the differences between PLLA and saline-treated specimens at 6 months compared to pre-treatment will also be analyzed: * β-catenin * PPARγ * Adipo
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Biopsies
Study Locations (1)
California
- Cosmetic Laser Dermatology/West Dermatology Research Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-08-30 |
What the registry record for NCT06656923 still lists
NCT06656923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 1 condition, with Lateral Gluteal Depression appearing as the primary indexed condition, and to 1 intervention - of which Biopsies is the first listed.
NCT06656923 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06656923 about?
NCT06656923 is a clinical study titled "Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical Trial of Poly-L-Lactic Acid for Adipogenesis and Volumization of the Hip Dell" Study". Primary Objective: use immunofluorescence (IF) on previously obtained biopsies to analyze and quantify changes in adipose tissue of subjects injected with poly-L-lactic acid (PLLA) or saline.
What is the current status of trial NCT06656923?
This trial is currently active not recruiting. The enrollment target is 14 participants. The study started on 2024-11-01. Estimated completion is 2025-08-30.
What conditions does trial NCT06656923 study?
This clinical trial studies the following conditions: Lateral Gluteal Depression.
What interventions are being tested in trial NCT06656923?
The interventions under investigation include: Biopsies (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06656923?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656923 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy